Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Internal Radiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06518018
What this trial is testing

Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Stage NSCLCSecond-line TreatmentPatients Without Targetable Driver Mutations
The First People's Hospital of Neijiang 80
Testing effectiveness (Phase 2)Looking for participantsNCT05894018
What this trial is testing

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft TissueBrachytherapyPoly(ADP-ribose) Polymerase Inhibitors
Fujun Zhang 32
Not applicableLooking for participantsNCT05440760
What this trial is testing

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Who this might be right for
Endocervical Cancer
University of Arkansas 20
Post-approval studies (Phase 4)Study completedNCT01798160
What this trial is testing

Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).

Who this might be right for
Hepatocellular Carcinoma
Johannes Gutenberg University Mainz 24
Not applicableStudy completedNCT03162523
What this trial is testing

Experiences With HDR-brachytherapy in Norway

Who this might be right for
Prostate Cancer
Oslo University Hospital 325
Not applicableUnknownNCT06431360
What this trial is testing

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

Who this might be right for
Keloid
Nanjing First Hospital, Nanjing Medical University 80
Not applicableLooking for participantsNCT05754580
What this trial is testing

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

Who this might be right for
Prostatic Cancer
University of Nebraska 53
Very early researchNot Yet RecruitingNCT07712770
What this trial is testing

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Who this might be right for
Recurrent Glioblastoma IDH WildtypeRecurrent Glioblastoma
Olivia Newton-John Cancer Research Institute 12
Large-scale testing (Phase 3)Ended earlyNCT00243646
What this trial is testing

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Who this might be right for
Prostate Cancer
Schiffler Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02805894
What this trial is testing

NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer
Nanobiotix 5
Testing effectiveness (Phase 2)UnknownNCT02565927
What this trial is testing

A Trail of a Novel Tracheal Radioactive Stent for the Malignant Airway Obstruction

Who this might be right for
Malignant Airway Obstruction
Zhongda Hospital 60
Not applicableNot Yet RecruitingNCT06093165
What this trial is testing

RE-irradiation of Diffuse MIdline Glioma paTients

Who this might be right for
Diffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine GliomaDiffuse Glioma+3 more
Rigshospitalet, Denmark 59
Testing effectiveness (Phase 2)WithdrawnNCT01802307
What this trial is testing

Focal Therapy for Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT02582034
What this trial is testing

Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

Who this might be right for
Adenoma, Liver Cell
Center Eugene Marquis 56
Testing effectiveness (Phase 2)Study completedNCT02280356
What this trial is testing

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT02692105
What this trial is testing

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 60
Not applicableUnknownNCT00459849
What this trial is testing

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Who this might be right for
Uveal Melanoma
Barnes Retina Institute 175
Not applicableStudy completedNCT07619768
What this trial is testing

Self Regulation Hypnotic Intervention for Pain and Anxiety During Rectal Brachytherapy

Who this might be right for
Rectal Cancer
Sir Mortimer B. Davis - Jewish General Hospital 52
Early research (Phase 1)Ended earlyNCT01058850
What this trial is testing

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

Who this might be right for
Brain CancerBrain Stem TumorsPontine Tumors
Paul Graham Fisher 3
Testing effectiveness (Phase 2)UnknownNCT04659382
What this trial is testing

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerpMMRMSS+2 more
Federation Francophone de Cancerologie Digestive 52
Next Page